Elevated serum CK18 levels in chronic hepatitis C patients are associated with advanced fibrosis but not steatosis

Journal of Viral Hepatitis

Volumn 19, Issue 4, 2012, Pages 278-282

  Jazwinski, A B ^a   Thompson, A J ^a   Clark, P J ^a   Naggie, S ^a   Tillmann, H L ^a   Patel, K ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

apoptosis; chronic hepatitis C; cytokeratin 18; fibrosis; steatosis

Indexed keywords

ALANINE AMINOTRANSFERASE; CYTOKERATIN 18;

ADULT; ARTICLE; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; HEPATITIS C; HISTOLOGY ACTIVITY INDEX; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL EXPERT; NONHUMAN; PRIORITY JOURNAL;

EID: 84858285166     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2011.01546.x     Document Type: Article

References (26)

1. Shepard CW, Finelli L, Alter MJ,. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005; 5 (9): 558-567. (Pubitemid 41196755)
2. Strader DB, Seeff LB,. The natural history of chronic hepatitis C infection. Eur J Gastroenterol Hepatol 1996; 8 (4): 324-328. (Pubitemid 26171215)
3. Seeff LB,. Natural history of chronic hepatitis C. Hepatology 2002; 36 (5 Suppl. 1): S35-S46. (Pubitemid 35253462)
4. Levine RA, Sanderson SO, Ploutz-Snyder R, et al. Assessment of fibrosis progression in untreated Irish women with chronic hepatitis C contracted from immunoglobulin anti-D. Clin Gastroenterol Hepatol 2006; 4 (10): 1271-1277. (Pubitemid 44512210)
5. Bach N, Thung SN, Schaffner F,. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 1992; 15 (4): 572-577.
6. Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM,. The pathology of hepatitis C. Hepatology 1992; 15 (4): 567-571.
7. Lefkowitch JH, Schiff ER, Davis GL, et al. Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group. Gastroenterology 1993; 104 (2): 595-603. (Pubitemid 23033436)
8. Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G,. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001; 33 (6): 1358-1364. (Pubitemid 32496971)
9. Poynard T, Ratziu V, McHutchison J, et al. Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C. Hepatology 2003; 38 (1): 75-85. (Pubitemid 36775798)
10. Lonardo A, Adinolfi LE, Loria P, Carulli N, Ruggiero G, Day CP,. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology 2004; 126 (2): 586-597. (Pubitemid 38182315)
11. Patton HM, Patel K, Behling C, et al. The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients. J Hepatol 2004; 40 (3): 484-490. (Pubitemid 38230851)
12. Rubbia-Brandt L, Fabris P, Paganin S, et al. Steatosis affects chronic hepatitis C progression in a genotype specific way. Gut 2004; 53 (3): 406-412. (Pubitemid 38241339)
13. Adams LA, Feldstein AE,. Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis. J Dig Dis 2011; 12 (1): 10-16.
14. Poynard T, Ratziu V, Charlotte F, et al. Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol 2006; 6: 34.
15. Papatheodoridis GV, Hadziyannis E, Tsochatzis E, et al. Serum apoptotic caspase activity in chronic hepatitis C and nonalcoholic Fatty liver disease. J Clin Gastroenterol 2010; 44 (4): e87-e95.
16. Bantel H, Lugering A, Heidemann J, et al. Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury. Hepatology 2004; 40 (5): 1078-1087. (Pubitemid 39425563)
17. Feldstein AE, Wieckowska A, Lopez AR, Liu YC, Zein NN, McCullough AJ,. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology 2009; 50 (4): 1072-1078.
18. Valva P, De Matteo E, Galoppo MC, Gismondi MI, Preciado MV,. Apoptosis markers related to pathogenesis of pediatric chronic hepatitis C virus infection: M30 mirrors the severity of steatosis. J Med Virol 2010; 82 (6): 949-957.
19. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994; 20 (1 pt 1): 15-20.
20. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1 (5): 431-435. (Pubitemid 12218164)
21. Feldstein AE, Canbay A, Angulo P, et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 2003; 125 (2): 437-443. (Pubitemid 36929425)
22. Bantel H, Ruck P, Gregor M, Schulze-Osthoff K,. Detection of elevated caspase activation and early apoptosis in liver diseases. Eur J Cell Biol 2001; 80 (3): 230-239. (Pubitemid 32241930)
23. Younossi ZM, Jarrar M, Nugent C, et al. A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH). Obes Surg 2008; 18 (11): 1430-1437.
24. Bantel H, Lugering A, Poremba C, et al. Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection. Hepatology 2001; 34 (4 pt 1): 758-767. (Pubitemid 32928001)
25. Walsh MJ, Vanags DM, Clouston AD, et al. Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury. Hepatology 2004; 39 (5): 1230-1238. (Pubitemid 38569044)
26. Seidel N, Volkmann X, Langer F, et al. The extent of liver steatosis in chronic hepatitis C virus infection is mirrored by caspase activity in serum. Hepatology 2005; 42 (1): 113-120. (Pubitemid 40911318)